Cargando…

Somatic Mutation of FAT Family Genes Implicated Superior Prognosis in Patients With Stomach Adenocarcinoma

FAT family genes encode protocadherin, which regulates tumor cell proliferation and migration. Although transcriptional levels of FAT family members had been reported in multiple malignant tumors, the association between mutation and prognosis of the FAT family in stomach adenocarcinoma (STAD) has n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qingjun, Cui, Liang, Li, Pansong, Wang, Yuanyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273734/ https://www.ncbi.nlm.nih.gov/pubmed/35836939 http://dx.doi.org/10.3389/fmed.2022.873836

Ejemplares similares

Development and Validation of a Novel Prognosis Prediction Model for Patients With Stomach Adenocarcinoma
por: Wang, Tong, et al.
Publicado: (2021)

The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma
por: Zhang, Xiulei, et al.
Publicado: (2020)

Somatic mutations in FAT cadherin family members constitute an underrecognized subtype of colorectal adenocarcinoma with unique clinicopathologic features
por: Wang, Liang-Li, et al.
Publicado: (2022)

A Multi-Gene Model Effectively Predicts the Overall Prognosis of Stomach Adenocarcinomas With Large Genetic Heterogeneity Using Somatic Mutation Features
por: Liu, Xianming, et al.
Publicado: (2020)

Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
por: Zhu, Mingyu, et al.
Publicado: (2022)

Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer
por: Yu, Yu, et al.
Publicado: (2021)

Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas
por: Menor, Mark, et al.
Publicado: (2019)

LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features
por: Yu, Jiaxian, et al.
Publicado: (2019)

The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma
por: Huang, Zhihao, et al.
Publicado: (2021)

Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma
por: Wang, Di, et al.
Publicado: (2023)

Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma
por: Xu, Zhiquan, et al.
Publicado: (2022)

DNA cytosine deamination is associated with recurrent Somatic Copy Number Alterations in stomach adenocarcinoma
por: Shi, Yilin, et al.
Publicado: (2023)

Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma
por: Han, Chen, et al.
Publicado: (2021)

Inferior Vena Cava Tumor Thrombus Secondary to Mucinous Adenocarcinoma of the Stomach
por: Tuck, Nicholas, et al.
Publicado: (2021)

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
por: Zhu, Mengxuan, et al.
Publicado: (2022)

The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis
por: Zhou, Kai, et al.
Publicado: (2020)

Multiple bioinformatics analysis identifies IGFBP1 as associated with the prognosis of stomach adenocarcinoma
por: Luo, Xiao-Ye, et al.
Publicado: (2023)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas
por: Wang, Xiaohui, et al.
Publicado: (2023)

Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets
por: Ren, Na, et al.
Publicado: (2020)

GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma
por: Ni, Lin, et al.
Publicado: (2023)

Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature
por: Fakhruddin, Najla, et al.
Publicado: (2017)

Improvement in prediction of prostate cancer prognosis with somatic mutational signatures
por: Zhang, Shengping, et al.
Publicado: (2017)

Acute Dilatation of the Stomach
Publicado: (1908)

High ADAMTS18 expression is associated with poor prognosis in stomach adenocarcinoma
por: Jiang, Kaiyuan, et al.
Publicado: (2020)

Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma
por: Shao, Changming, et al.
Publicado: (2021)

Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis
por: Hong, Chunhong, et al.
Publicado: (2021)

Exploration of KCNJ5 Somatic Mutation and CYP11B1/CYP11B2 Staining in Multiple Nodules in Primary Aldosteronism
por: Xie, Jing, et al.
Publicado: (2022)

Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients
por: Zhu, Chunchao, et al.
Publicado: (2019)

Effect of Hyperglycemia on Purinergic and Nitrergic Inhibitory Neuromuscular Transmission in the Antrum of the Stomach: Implications for Fast Gastric Emptying
por: He, Xue-Dao, et al.
Publicado: (2018)

Somatic mutations combined with clinical features can predict the postoperative prognosis of stage IIIA lung adenocarcinoma
por: Li, Jiuzhen, et al.
Publicado: (2022)

Identification of mitochondrial respiratory chain signature for predicting prognosis and immunotherapy response in stomach adenocarcinoma
por: Yang, Jing, et al.
Publicado: (2023)

Gas in the Stomach and Its Treatment
Publicado: (1911)

Features of alternative splicing in stomach adenocarcinoma and their clinical implication: a research based on massive sequencing data
por: Zhang, Yuanyuan, et al.
Publicado: (2020)

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma
por: Fu, Min, et al.
Publicado: (2022)

Identification of miRNA biomarkers for stomach adenocarcinoma
por: Qian, Hao, et al.
Publicado: (2022)

Landscape of somatic mutations in gastric cancer assessed using next-generation sequencing analysis
por: Pan, Xuan, et al.
Publicado: (2018)

Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma
por: Yu, Tao, et al.
Publicado: (2022)

Susceptibility Factors of Stomach for SARS-CoV-2 and Treatment Implication of Mucosal Protective Agent in COVID-19
por: Zhang, Min, et al.
Publicado: (2021)

Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
por: Li, He, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d9g4b58dk7jso5eo0uaqmikclf